Literature DB >> 5035134

A rehabilitation program for improving exercise tolerance of patients with chronic lung disease.

C R Woolf.   

Abstract

A Chronic Chest Disease Rehabilitation Program has been developed in the Toronto General Hospital to improve exercise tolerance in very disabled patients. The most important part of the program is physical conditioning using mainly a motor-driven treadmill. The treadmill exercise is done breathing room air or, in the case of the most disabled patients, an oxygen-enriched gas mixture. Other exercise includes riding a stationary bicycle, going up and down stairs, and turning a wheel by hand. Other aspects of the program are breathing exercises, inhalation therapy using an ultrasonic nebulizer, chest physiotherapy, and patient education. The importance of a team approach with encouragement, enthusiasm and demonstration of steady progress is emphasized.

Entities:  

Mesh:

Year:  1972        PMID: 5035134      PMCID: PMC1940432     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  5 in total

1.  The diagnostic use of an ear oximeter in congenital heart disease.

Authors:  C R WOOLF; W PAUL; R W GUNTON
Journal:  Br Heart J       Date:  1958-07

2.  Response to exercise in patients with chronic airway obstruction. I. Effects of exercise training.

Authors:  M N Vyas; E W Banister; J W Morton; S Grzybowski
Journal:  Am Rev Respir Dis       Date:  1971-03

3.  Alterations in lung mechanics and gas exchange following training in chronic obstructive lung disease.

Authors:  C R Woolf; J T Suero
Journal:  Dis Chest       Date:  1969-01

4.  The role of oxygen therapy in the rehabilitation of patients with chronic obstructive pulmonary disease.

Authors:  A M Longo; K M Moser; P C Luchsinger
Journal:  Am Rev Respir Dis       Date:  1971-05

5.  The physiologic basis of training patients with emphysema.

Authors:  P N Paez; E A Phillipson; M Masangkay; B J Sproule
Journal:  Am Rev Respir Dis       Date:  1967-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.